Newz(OCUL) on Monday reported a loss of $78.8 million in its second quarter. The Bedford, Massachusetts-based company said it had a loss of 35 cents per share. The results surpassed Wall Street expectations.
The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 40 cents per share. The biotechnology company posted revenue of $13.5 million in the period, also exceeding Street forecasts. Four analysts surveyed by Zacks expected $12.7 million.
_____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCUL at https://www.zacks.com/ap/OCUL Source (TGTX) on Monday reported second-quarter net income of $7.8 million.
The Morrisville, North Carolina-based company said it had net income of 5 cents per share. The results did not meet Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share.
The biopharmaceutical company posted revenue of $240.3 million in the period, topping Street forecasts. Three analysts surveyed by Zacks expected $230.9 million. TG Therapeutics expects full-year revenue of $950 million.
Access a Zacks stock report on TGTX at https://www.zacks.com/ap/TGTX Source
Summary from source